Ansidex is manufactured by Baxter Pharmaceuticals India Private Limited and registered by Baxter Healthcare (Asia) PTE Ltd., which belongs to the group of psychotropic drugs. In order to use the drug effectively, patients need to learn some information about the uses, dosage and notes when using Ansidex in the article below.

Prolonged mechanical ventilation will cause patients to be at risk of hospital-acquired infections, lung damage, and even death. The process of weaning from mechanical ventilation requires a lot of effort, monitoring, and caution because the patient may encounter risks such as cardiovascular disorders, gas exchange disorders, increased respiratory work, muscle fatigue, etc. leading to failure in weaning from mechanical ventilation. So what should be done when weaning from mechanical ventilation fails?

Prolonged mechanical ventilation will have many risks of hospital infection, lung damage, on the other hand, the treatment cost is expensive but still has the risk of causing death for the patient. Therefore, for patients on mechanical ventilation, the process of weaning from the ventilator needs to be quickly assessed so that the ventilator can be removed as soon as possible. This process needs to be considered right from the beginning of mechanical ventilation.

Weaning from a ventilator is the process of gradually reducing the support of the ventilator and gradually increasing the patient's natural breathing to achieve the target when removing the ventilator. This process can take place from several days to several weeks, even months. Weaning a patient from a ventilator when: the cause of ventilation has been treated, gas exchange is maintained with the lowest level of support (ability to breathe on your own < 30 breaths/minute)...

During mechanical ventilation, a machine helps the patient breathe by delivering an air-oxygen mixture into the patient's lungs, either through an endotracheal tube or tracheostomy tube (invasive mechanical ventilation) or through a mask (non-invasive mechanical ventilation) until the patient can breathe effectively on his or her own.

Artificial ventilation is indicated when the patient has oxygen deficiency and reduced alveolar ventilation. This is considered a method that can partially or completely replace the patient's spontaneous breathing rhythm.

Thoracic surgery is a major surgery that has many potential complications, risks and dangers that can occur during and after surgery. Anesthesia methods in thoracic surgery include intravenous anesthesia and endotracheal anesthesia. Anesthesia in thoracic surgery can be combined with epidural anesthesia.

Patients are considered difficult to wean from mechanical ventilation if they fail the first spontaneous breathing trial (SBT) and require three SBTs or seven days to successfully achieve SBT. Up to 40% of patients on mechanical ventilation for acute illness in ICUs are difficult to wean from mechanical ventilation.

Acute pulmonary edema is an urgent emergency, causing acute respiratory failure because the alveoli (lungs) are filled with fluid, leading to the inability to exchange air (take in O2 and release C02). If detected, diagnosed early, and treated promptly, the disease can recover quickly. If not treated promptly, it will lead to severe acute respiratory failure, with a high risk of death.

Mechanical ventilation, also known as mechanical ventilation, is a procedure to assist or control breathing in surgical or life-threatening situations. Patients need to use a ventilator to support their breathing and airway.

After the patient is removed from the ventilator but the endotracheal tube cannot be extubated, the operator will let the patient breathe in a T-tube. The T-tube can breathe through a tracheostomy tube or through an endotracheal tube.